1. Home
  2. TGNA vs RARE Comparison

TGNA vs RARE Comparison

Compare TGNA & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TGNA
  • RARE
  • Stock Information
  • Founded
  • TGNA 1906
  • RARE 2010
  • Country
  • TGNA United States
  • RARE United States
  • Employees
  • TGNA N/A
  • RARE N/A
  • Industry
  • TGNA Broadcasting
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TGNA Industrials
  • RARE Health Care
  • Exchange
  • TGNA Nasdaq
  • RARE Nasdaq
  • Market Cap
  • TGNA 3.3B
  • RARE 3.0B
  • IPO Year
  • TGNA N/A
  • RARE 2014
  • Fundamental
  • Price
  • TGNA $19.94
  • RARE $32.62
  • Analyst Decision
  • TGNA Buy
  • RARE Strong Buy
  • Analyst Count
  • TGNA 4
  • RARE 14
  • Target Price
  • TGNA $20.00
  • RARE $86.64
  • AVG Volume (30 Days)
  • TGNA 2.6M
  • RARE 1.6M
  • Earning Date
  • TGNA 11-06-2025
  • RARE 11-04-2025
  • Dividend Yield
  • TGNA 2.51%
  • RARE N/A
  • EPS Growth
  • TGNA 15.85
  • RARE N/A
  • EPS
  • TGNA 2.77
  • RARE N/A
  • Revenue
  • TGNA $3,032,450,000.00
  • RARE $610,159,000.00
  • Revenue This Year
  • TGNA N/A
  • RARE $19.72
  • Revenue Next Year
  • TGNA $11.44
  • RARE $23.29
  • P/E Ratio
  • TGNA $7.20
  • RARE N/A
  • Revenue Growth
  • TGNA 5.89
  • RARE 26.77
  • 52 Week Low
  • TGNA $14.87
  • RARE $25.81
  • 52 Week High
  • TGNA $21.35
  • RARE $57.97
  • Technical
  • Relative Strength Index (RSI)
  • TGNA 42.14
  • RARE 57.75
  • Support Level
  • TGNA $19.73
  • RARE $30.95
  • Resistance Level
  • TGNA $20.38
  • RARE $34.50
  • Average True Range (ATR)
  • TGNA 0.21
  • RARE 1.22
  • MACD
  • TGNA -0.09
  • RARE 0.31
  • Stochastic Oscillator
  • TGNA 25.32
  • RARE 59.23

About TGNA TEGNA Inc

Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: